 | • レポートコード：MRC2302F0220 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、240ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年の488.34百万ドルであった世界の動物用分子診断市場規模が、2022年に531.77百万ドルへ達し、2027年までに年平均9.07%成長し、822.25百万ドルへ拡大すると見込んでいます。本書は、動物用分子診断の世界市場を対象に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（機器・ソフトウェア、キット・試薬、サービス）分析、技術別（DNAシークエンシング、マイクロアレイ、ポリメラーゼ連鎖反応（PCR））分析、動物種類別（コンパニオン動物、家畜動物）分析、疾患別（下痢病原体検出、呼吸器病原体検出、昆虫媒介性疾病）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目について調査・分析を行っています。また、市場調査の対象企業には、Biochek BV、Biomedica Medizinprodukte GmbH、BioMérieux SA、Bioneer Corp、Core Imaging LLC、Cree, Inc.、HealthGene Corporation、Heska Corporation、IDEXX Laboratories, Inc.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の動物用分子診断市場規模：製品別 - 機器・ソフトウェアの市場規模 - キット・試薬の市場規模 - サービスの市場規模 ・世界の動物用分子診断市場規模：技術別 - DNAシークエンシング法動物用分子診断の市場規模 - マイクロアレイ法動物用分子診断の市場規模 - ポリメラーゼ連鎖反応（PCR）法動物用分子診断の市場規模 ・世界の動物用分子診断市場規模：動物種類別 - コンパニオン動物における市場規模 - 家畜動物における市場規模 ・世界の動物用分子診断市場規模：疾患別 - 下痢病原体検出における市場規模 - 呼吸器病原体検出における市場規模 - 昆虫媒介性疾病における市場規模 ・世界の動物用分子診断市場規模：地域別 - 南北アメリカの動物用分子診断市場規模 アメリカの動物用分子診断市場規模 カナダの動物用分子診断市場規模 ブラジルの動物用分子診断市場規模 ... - アジア太平洋の動物用分子診断市場規模 日本の動物用分子診断市場規模 中国の動物用分子診断市場規模 インドの動物用分子診断市場規模 韓国の動物用分子診断市場規模 台湾の動物用分子診断市場規模 ... - ヨーロッパ/中東/アフリカの動物用分子診断市場規模 イギリスの動物用分子診断市場規模 ドイツの動物用分子診断市場規模 フランスの動物用分子診断市場規模 ロシアの動物用分子診断市場規模 ... - その他地域の動物用分子診断市場規模 ・競争状況 ・企業情報 |
The Global Veterinary Molecular Diagnostic Market size was estimated at USD 488.34 million in 2021 and expected to reach USD 531.77 million in 2022, and is projected to grow at a CAGR 9.07% to reach USD 822.25 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Veterinary Molecular Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Instruments & Software, Kits & Reagent, and Services.
Based on Technology, the market was studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction.
Based on Animal Type, the market was studied across Companion Animal and Livestock Animal. The Companion Animal is further studied across Canine, Equine, and Feline. The Livestock Animal is further studied across Bovine, Ovine or Caprine, Porcine, and Poultry.
Based on Disease Indication, the market was studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases.
Based on End User, the market was studied across Hospitals or Clinics and Reference Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Veterinary Molecular Diagnostic market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Molecular Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Molecular Diagnostic Market, including Biochek BV, Biomedica Medizinprodukte GmbH, BioMérieux SA, Bioneer Corp, Core Imaging LLC, Cree, Inc., HealthGene Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, Neogen Corporation, Novacyt Group, Qiagen N.V., Quality Vet Lab, Randox Laboratories, Ltd, Thermo Fisher Scientific, Inc., VCA, Inc., Veterinary Molecular Diagnostics Inc., Virbac S.A., and Zoetis Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Veterinary Molecular Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Molecular Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Molecular Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Veterinary Molecular Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Veterinary Molecular Diagnostic Market?
6. What is the market share of the leading vendors in the Global Veterinary Molecular Diagnostic Market?
7. What modes and strategic moves are considered suitable for entering the Global Veterinary Molecular Diagnostic Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of various animal zoonotic diseases
5.1.1.2. Growing number of veterinary diagnostic centres along with practitioners
5.1.1.3. Rising demand for pet insurance and growing importance of animal health
5.1.2. Restraints
5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
5.1.3. Opportunities
5.1.3.1. Growing adoption of advanced diagnostic techniques
5.1.3.2. Entry of new vaccines and increasing adoption of new tools
5.1.4. Challenges
5.1.4.1. Lack of skilled technicians
5.2. Cumulative Impact of COVID-19
6. Veterinary Molecular Diagnostic Market, by Product
6.1. Introduction
6.2. Instruments & Software
6.3. Kits & Reagent
6.4. Services
7. Veterinary Molecular Diagnostic Market, by Technology
7.1. Introduction
7.2. DNA Sequencing
7.3. Microarrays
7.4. Polymerase Chain Reaction
8. Veterinary Molecular Diagnostic Market, by Animal Type
8.1. Introduction
8.2. Companion Animal
8.3.1. Canine
8.3.2. Equine
8.3.3. Feline
8.3. Livestock Animal
8.4.1. Bovine
8.4.2. Ovine or Caprine
8.4.3. Porcine
8.4.4. Poultry
9. Veterinary Molecular Diagnostic Market, by Disease Indication
9.1. Introduction
9.2. Diarrhea Pathogens Detection
9.3. Respiratory Pathogens Detection
9.4. Vector Borne Diseases
10. Veterinary Molecular Diagnostic Market, by End User
10.1. Introduction
10.2. Hospitals or Clinics
10.3. Reference Laboratories
11. Americas Veterinary Molecular Diagnostic Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Veterinary Molecular Diagnostic Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Biochek BV
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Biomedica Medizinprodukte GmbH
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. BioMérieux SA
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Bioneer Corp
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Core Imaging LLC
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Cree, Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. HealthGene Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Heska Corporation
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. IDEXX Laboratories, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. IDvet
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. INDICAL BIOSCIENCE GmbH
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Ingenetix GmbH
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Neogen Corporation
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Novacyt Group
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Qiagen N.V.
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Quality Vet Lab
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Randox Laboratories, Ltd
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Thermo Fisher Scientific, Inc.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. VCA, Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Veterinary Molecular Diagnostics Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Virbac S.A.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services
15.22. Zoetis Inc.
15.22.1. Business Overview
15.22.2. Key Executives
15.22.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing